Victory Capital: Multiple Avenues Of Growth

Victory Capital (VCTR) is reiterated as a Buy, citing strong 1Q26 results: revenue +77% YoY and adjusted EBITDA +75% YoY, alongside stable fee rates despite industry-wide fee compression. The firm’s M&A/integration track record (e.g., Pioneer) and ETF product expansion are expected to keep revenue, EBITDA, and EPS growth above sector and historical averages. Overall, the earnings beat versus expectations is the primary near-term positive catalyst.

Analysis

The market is likely underestimating how much of VCTR’s earnings power is now coming from mix and scale rather than pure market beta. If the firm can keep adding AUM through acquisition and ETF shelf expansion while holding fee rates flat, it deserves a premium versus legacy active managers whose earnings are still being eroded by passive migration and outflows. The second-order read-through is negative for subscale managers with weaker distribution or no M&A currency, because consolidation plus product breadth can widen the gap in operating leverage and free cash flow conversion.

Near term, the stock can keep working if the next print confirms that integration costs are not reaccelerating and that organic flows are not just market-driven. The key reversal risk is that headline AUM growth masks lower-quality inflows or that additional acquisitions create a larger low-fee ETF mix, which can suppress long-run margin even if EPS beats in the next 1-2 quarters. For the sector, any relief in fee compression would help all asset managers, but absent that, VCTR’s relative outperformance depends on execution staying cleaner than peers.

The contrarian view is that the market may already be paying for the obvious synergy story while underpricing integration and platform concentration risk. If deal-related growth slows for even one quarter, the multiple could compress quickly because the equity case is now tied to repeatable acquisition-driven compounding, not just market appreciation. Watch for guidance revisions, net flow trends, and post-close synergy capture versus integration drag over the next 1-3 quarters; that will determine whether this is a re-rating story or just a one-off earnings beat.

Key Decisions for Investors

• Long VCTR on post-earnings weakness or any pullback toward the 20-day moving average; thesis is 3-6 month EPS revision upside if AUM growth and fee stability persist. Stop if organic net flows decelerate materially or management trims synergy targets.
• Pair trade: long VCTR / short BEN or IVZ over the next 1-3 months. Use it as a relative-value expression on platform scale and M&A execution versus legacy active-manager fee pressure; thesis fails if sector-wide fee pressure eases or VCTR integration stumbles.
• Buy 3-6 month call spreads on VCTR rather than outright calls if implied vol remains reasonable. Best risk/reward is when the market is skeptical about sustainability of the beat; cap upside but protect against multiple compression if the next quarter is merely in-line.
• Set an alert on fee-rate commentary and ETF mix changes at the next earnings update. If lower-fee product growth starts outpacing high-margin AUM, take profits on the long because margin durability becomes the key bear case.